Secondary prevention of acute cerebrovascular failures - pharmaco-economical aspects of problem

.

Bibliographic Details
Main Author: A. V. Rudakova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2007-10-01
Series:Российский кардиологический журнал
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2230
_version_ 1826561552420962304
author A. V. Rudakova
author_facet A. V. Rudakova
author_sort A. V. Rudakova
collection DOAJ
description .
first_indexed 2024-04-09T20:53:39Z
format Article
id doaj.art-d9959e506f0747ea91276c5abb3e9dec
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2025-03-14T09:33:59Z
publishDate 2007-10-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-d9959e506f0747ea91276c5abb3e9dec2025-03-02T11:42:24Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202007-10-010579821982Secondary prevention of acute cerebrovascular failures - pharmaco-economical aspects of problemA. V. Rudakova0Военно-медицинская академия.https://russjcardiol.elpub.ru/jour/article/view/2230
spellingShingle A. V. Rudakova
Secondary prevention of acute cerebrovascular failures - pharmaco-economical aspects of problem
Российский кардиологический журнал
title Secondary prevention of acute cerebrovascular failures - pharmaco-economical aspects of problem
title_full Secondary prevention of acute cerebrovascular failures - pharmaco-economical aspects of problem
title_fullStr Secondary prevention of acute cerebrovascular failures - pharmaco-economical aspects of problem
title_full_unstemmed Secondary prevention of acute cerebrovascular failures - pharmaco-economical aspects of problem
title_short Secondary prevention of acute cerebrovascular failures - pharmaco-economical aspects of problem
title_sort secondary prevention of acute cerebrovascular failures pharmaco economical aspects of problem
url https://russjcardiol.elpub.ru/jour/article/view/2230
work_keys_str_mv AT avrudakova secondarypreventionofacutecerebrovascularfailurespharmacoeconomicalaspectsofproblem